Insider · CIK 0001405290
Quang X Pham
Files at CVKD (Cadrenal Therapeutics, Inc.). First filing Aug 29, 2025, latest Jul 1, 2026.
In brief
Quang X Pham files SEC Form 4 as CEO, chair, director, 10% owner and CFO at CVKD (Cadrenal Therapeutics, Inc.). Since Aug 29, 2025, Quang X Pham has reported 0 open-market buys worth $0 and 16 open-market sells worth $701k, the latest filed on Jul 1, 2026.
A track record needs three past buys with six months of prices behind them; Quang X Pham has 0, so none is measured yet.
The newest scored trade: sold $22k of CVKD on Jun 29, 2026, filed Jul 1, 2026, scored 5 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 12 sells worth $473k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CVKD: Cadrenal Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 5Weak | Cadrenal Therapeutics, Inc. | $22k 7,400 shares | -7% | +6% from low-79% from high | |
| 11Weak | Cadrenal Therapeutics, Inc. | $34k 11,156 shares | -10% | 0% from low-80% from high | |
| 11Weak | Cadrenal Therapeutics, Inc. | $40k 11,444 shares | -9% | +5% from low-78% from high | |
| 5Weak | Cadrenal Therapeutics, Inc. | $13k 4,126 shares | -3% | 0% from low-79% from high | |
| 18Weak | Cadrenal Therapeutics, Inc. | $70k 18,124 shares | -12% | +2% from low-73% from high | |
| 20Weak | Cadrenal Therapeutics, Inc. | $93k 22,385 shares | -13% | +0% from low-72% from high | |
| 11Weak | Cadrenal Therapeutics, Inc. | $36k 8,285 shares | -5% | 0% from low-73% from high | |
| 5Weak | Cadrenal Therapeutics, Inc. | $3,075 652 shares | -0% | +17% from low-68% from high | |
| 13Weak | Cadrenal Therapeutics, Inc. | $69k 12,763 shares | -7% | +30% from low-65% from high | |
| 5Weak | Cadrenal Therapeutics, Inc. | $6,629 1,165 shares | -1% | +22% from low-66% from high | |
| 19Weak | Cadrenal Therapeutics, Inc. | $34k 2,444 shares | -1% | - | |
| 20Weak | Cadrenal Therapeutics, Inc. | $51k 3,600 shares | -2% | - | |
| 13Weak | Cadrenal Therapeutics, Inc. | $7,065 500 shares | -0% | - | |
| 13Weak | Cadrenal Therapeutics, Inc. | $18k 1,300 shares | -1% | - | |
| 24Weak | Cadrenal Therapeutics, Inc. | $132k 9,371 shares | -4% | - | |
| 21Weak | Cadrenal Therapeutics, Inc. | $70k 5,029 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 15, 2026 | CVKD CADRENAL THERAPEUTICS, INC. | 40,000 1.39% of outstanding | $148k | Jun 15, 2026 | $266k |
| May 11, 2026 | CVKD CADRENAL THERAPEUTICS, INC. | 60,000 2.09% of outstanding | $349k | May 11, 2026 | none |
| Oct 27, 2025 | CVKD CADRENAL THERAPEUTICS, INC. | 1,315 0.06% of outstanding | $18k | Oct 27, 2025 | $294k |
| Oct 24, 2025 | CVKD CADRENAL THERAPEUTICS, INC. | 1,129 0.06% of outstanding | $16k | Oct 24, 2025 | $278k |
| Oct 14, 2025 | CVKD CADRENAL THERAPEUTICS, INC. | 1,800 0.09% of outstanding | $25k | Oct 13, 2025 | $252k |
| Oct 9, 2025 | CVKD CADRENAL THERAPEUTICS, INC. | 1,800 0.09% of outstanding | $25k | Oct 9, 2025 | $227k |
| Oct 2, 2025 | CVKD CADRENAL THERAPEUTICS, INC. | 500 0.02% of outstanding | $7,066 | Oct 2, 2025 | $220k |
| Oct 1, 2025 | CVKD CADRENAL THERAPEUTICS, INC. | 881 0.04% of outstanding | $12k | Oct 1, 2025 | $208k |
| Sep 29, 2025 | CVKD Cadrenal TheraputicsINC | 419 0.02% of outstanding | $5,870 | Sep 29, 2025 | $202k |
| Sep 25, 2025 | CVKD Cadrenal TheraputicsINC | 6,790 0.33% of outstanding | $96k | Sep 24, 2025 | $106k |
| Sep 24, 2025 | CVKD Cadrenal TheraputicsINC | 2,581 0.13% of outstanding | $36k | Sep 24, 2025 | $70k |
| Aug 28, 2025 | CVKD Cadrenal Therapeutics, Inc. | 1,193 0.06% of outstanding | $17k | Aug 28, 2025 | $53k |
| Aug 27, 2025 | CVKD Cadrenal Therapeutics, Inc. | 30,600 1.49% of outstanding | $428k | Aug 27, 2025 | none |
Transactions
Every row this insider has filed, 34 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -7,400 | $3.03 | $22k | 98,589 | Jul 1, 2026 |
| Jun 25, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,127 | $3.00 | $6,381 | 115,018 | Jun 26, 2026 |
| Jun 26, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -9,029 | $3.05 | $28k | 105,989 | Jun 26, 2026 |
| Jun 22, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -9,167 | $3.55 | $33k | 119,422 | Jun 24, 2026 |
| Jun 23, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,277 | $3.20 | $7,286 | 117,145 | Jun 24, 2026 |
| Jun 16, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,613 | $3.18 | $11k | 129,102 | Jun 18, 2026 |
| Jun 17, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -513 | $3.16 | $1,621 | 128,589 | Jun 18, 2026 |
| Jun 11, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,462 | $4.12 | $6,023 | 149,377 | Jun 15, 2026 |
| Jun 12, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -12,996 | $3.94 | $51k | 136,381 | Jun 15, 2026 |
| Jun 15, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,666 | $3.58 | $13k | 132,715 | Jun 15, 2026 |
| Jun 8, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,893 | $4.38 | $26k | 167,331 | Jun 10, 2026 |
| Jun 9, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -12,992 | $4.06 | $53k | 154,339 | Jun 10, 2026 |
| Jun 10, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,500 | $4.21 | $15k | 150,839 | Jun 10, 2026 |
| Jun 3, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,323 | $4.26 | $9,896 | 179,186 | Jun 5, 2026 |
| Jun 4, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,898 | $4.41 | $17k | 175,288 | Jun 5, 2026 |
| Jun 5, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,064 | $4.42 | $9,123 | 173,224 | Jun 5, 2026 |
| May 29, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -303 | $5.01 | $1,518 | 181,858 | Jun 2, 2026 |
| Jun 2, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -349 | $4.46 | $1,557 | 181,509 | Jun 2, 2026 |
| May 11, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,476 | $5.76 | $37k | 188,448 | May 29, 2026 |
| May 12, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,298 | $5.28 | $17k | 185,150 | May 29, 2026 |
| May 28, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,989 | $4.93 | $15k | 182,161 | May 29, 2026 |
| May 22, 2026 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,165 | $5.69 | $6,629 | 194,924 | May 26, 2026 |
| Oct 24, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,129 | $14.03 | $16k | 197,404 | Oct 28, 2025 |
| Oct 27, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,315 | $13.99 | $18k | 196,089 | Oct 28, 2025 |
| Oct 9, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,800 | $14.02 | $25k | 200,333 | Oct 14, 2025 |
| Oct 13, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,800 | $14.15 | $25k | 198,533 | Oct 14, 2025 |
| Oct 2, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -500 | $14.13 | $7,065 | 202,133 | Oct 3, 2025 |
| Sep 29, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -419 | $14.01 | $5,870 | 203,514 | Oct 1, 2025 |
| Oct 1, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -881 | $14.01 | $12k | 202,633 | Oct 1, 2025 |
| Sep 24, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,581 | $13.99 | $36k | 210,723 | Sep 26, 2025 |
| Sep 25, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,790 | $14.09 | $96k | 203,933 | Sep 26, 2025 |
| Aug 27, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,836 | $13.99 | $54k | 214,497 | Aug 29, 2025 |
| Aug 28, 2025 | CVKD Cadrenal Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,193 | $13.99 | $17k | 213,304 | Aug 29, 2025 |
| Jan 23, 2025 | CVKD Cadrenal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +65,000 | $0.00 | $0 | 65,000 | Jan 24, 2025 |
Questions about Quang X Pham
Answered from the filings on this page, as of the latest one.
Is Quang X Pham buying or selling?
In the last 12 months Quang X Pham reported 0 open-market buys worth $0 and 12 open-market sells worth $473k on SEC Form 4; the latest was sold $22k of CVKD on Jun 29, 2026. Grants, option exercises and tax withholding are not counted.
How did Quang X Pham's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Quang X Pham has 0.
Where does Quang X Pham file Form 4?
Quang X Pham has filed Form 4 at CVKD (Cadrenal Therapeutics, Inc.) as Chairman and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.